Outcomes and mortality associated with atrial arrhythmias among patients hospitalized with COVID‐19. (14th October 2020)

• Record Type: Journal Article
• Authors: Peltzer, Bradley; Manocha, Kevin K.; Ying, Xiaohan; Kirzner, Jared; Ip, James E.; Thomas, George; Liu, Christopher F.; Markowitz, Steven M.; Lerman, Bruce B.; Safford, Monika M.; Goyal, Parag; Cheung, Jim W.
• Is Part Of: Journal of cardiovascular electrophysiology. Volume 31:Number 12(2020)
• Page Start: 3077
• Page End: 3085
• Publication Date: 2020-10-14
• Subjects: atrial fibrillation -- atrial flutter -- COVID‐19 -- mortality -- outcomes; Blood vessels -- Physiology -- Periodicals; Electrophysiology -- Periodicals; Heart -- Physiology -- Periodicals; 612.1
• DOI: 10.1111/jce.14770
• Languages: English
• ISSNs: 1045-3873

Abstract

Abstract: Introduction: The impact of atrial arrhythmias on coronavirus disease 2019 (COVID‐19)‐associated outcomes are unclear. We sought to identify prevalence, risk factors and outcomes associated with atrial arrhythmias among patients hospitalized with COVID‐19. Methods: An observational cohort study of 1053 patients with severe acute respiratory syndrome coronavirus 2 infection admitted to a quaternary care hospital and a community hospital was conducted. Data from electrocardiographic and telemetry were collected to identify atrial fibrillation (AF) or atrial flutter/tachycardia (AFL). The association between atrial arrhythmias and 30‐day mortality was assessed with multivariable analysis. Results: Mean age of patients was 62 ± 17 years and 62% were men. Atrial arrhythmias were identified in 166 (15.8%) patients, with AF in 154 (14.6%) patients and AFL in 40 (3.8%) patients. Newly detected atrial arrhythmias occurred in 101 (9.6%) patients. Age, male sex, prior AF, renal disease, and hypoxia on presentation were independently associated with AF/AFL occurrence. Compared with patients without AF/AFL, patients with AF/AFL had significantly higher levels of troponin, B‐type natriuretic peptide, C‐reactive protein, ferritin and d ‐dimer. Mortality was significantly higher among patients with AF/AFL (39.2%) compared to patients without (13.4%; p < .001). After adjustment for age and co‐morbidities, AF/AFL (adjusted odds ratio [OR]: 1.93; p = .007) and newly detected AF/AFL (adjusted OR: 2.87; p < .001) were independently associated with 30‐day mortality. Conclusion: Atrial arrhythmias are common among patients hospitalized with COVID‐19. The presence of AF/AFL tracked with markers of inflammation and cardiac injury. Atrial arrhythmias were independently associated with increased mortality.